Dr. Kimberly Ong of Vireo Advisors, LLC is pleased to serve on the board of NanoCanada’s Canadian Safety and Health Initiative for Nanotechnology and Advanced Materials and invites you to register for the webinar, “Nanotechnology regulation in Canada, the United States, and the European Union” on May 5, 2021.
Read MoreVireo Advisors is collaborating with Health Canada and two European Horizon2020 projects to coordinate two back-to-back workshops at the OECD: “Advancing Adverse Outcome Pathway (NanoAOP) Development for Nanomaterial Risk Assessment and Categorization” (NanoAOP Workshop), to be held 11 September 2019, and a stakeholder workshop organized by the EU H2020 Project Physiologically Anchored Tools for Realistic nanOmateriaL hazard aSsessment (PATROLS ), to be held 12 September 2019.
Read MoreDr. Kimberly Ong of Vireo Advisors will present Vireo’s ongoing collaborative work* entitled, "Advancing Adverse Outcome Pathways as a Tool for the Risk Assessment of Nanomaterials – the NanoAOP Project", during NanoCanada's first national conference: Converging on Nanomanufacturing from September 25-26, 2017 in Montréal, Canada.
Read MoreHealth Canada and Environment and Climate Change Canada are currently in the process of completing a prioritization of nanomaterials on their Domestic Substances List.
Read More